PDCD1 and neoplasm: The first profile is characterized by the presence of tumor-infiltrating lymphocytes in the tumor bed, together with myeloid cells and monocytic cells; the infiltrating immune cells and, in some cases, tumor cells exhibit checkpoint activation, i.e., programmed cell death protein 1 (PD-1) and its ligand (PD-L1).